trending Market Intelligence /marketintelligence/en/news-insights/trending/jtl01cyg1xqyyiqzhaxdaw2 content esgSubNav
In This List

Immune Pharmaceuticals director resigns

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Immune Pharmaceuticals director resigns

Immune Pharmaceuticals Inc. said Cameron Durrant resigned as a director.

Englewood Cliffs, N.J.-based Immune Pharmaceuticals develops treatments for immunologic and inflammatory diseases.